Hormone therapy in prostate cancer

Geoffrey M. Currie*, Matthew Haase, Rashid Hashmi, Hosen Kiat

*Corresponding author for this work

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    The role of nuclear medicine diagnostic bone scanning is well established in prostate cancer. This case provides an insight into the specific role that bone scanning plays in monitoring response to hormone therapy and an example of significant global skeletal response. The case highlights the remarkable efficacy of timely hormone therapy in high-grade prostate cancer with widespread bony metastasis. In addition, the range of hormone therapy currently available for clinical application in the management of metastatic prostate cancer is detailed. Finally, the case represents an incidental diagnosis of prostate cancer after evaluation of nonspecific symptoms.

    Original languageEnglish
    Pages (from-to)49-51
    Number of pages3
    JournalJournal of Nuclear Medicine Technology
    Volume41
    Issue number1
    DOIs
    Publication statusPublished - Mar 2013

    Fingerprint Dive into the research topics of 'Hormone therapy in prostate cancer'. Together they form a unique fingerprint.

    Cite this